The application of lipase from Burkholderia cepacia in the enantioselective pharmaceutical biocatalysis

The application of lipase from Burkholderia cepacia in the enantioselective pharmaceutical biocatalysis

Lipases are widely applied catalysts in the pharmaceutical and biotechnological industries. They are characterized by high catalytic activity, and stability and are environmentally friendly. These enzymes could be used in free and in immobilized form. The immobilization procedure is exerted to impro...

Full description

Bibliographic Details
Main Authors:	Jacek Dulęba, Tomasz Siódmiak, Rafał Mastalerz, Natalia Kocot, Agnieszka Dębińska, Emilia Suchomska, Mateusz Czeczka, Kamil Cała, Michał Piotr Marszałł
Format:	Article
Language:	Polish
Published:	Polish Pharmaceutical Society 2022-06-01
Series:	Farmacja Polska
Subjects:	immobilization chiral drugs lipase from burkholderia cepacia enantioselectivity chiral intermediates
Online Access:	https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2022%2F4%2F03_OG_Lipaza_BCL_n.pdf

Similar Items

The Effect of Temperature on the Enantioselectivity of Lipase-Catalyzed Reactions; Case Study: Isopropylidene Glycerol Reaction
by: Adnan AYDEMİR
Published: (2022-05-01)

The Application of Two-Phase Catalytic System in Enantioselective Separation of Racemic (<i>R</i>,<i>S</i>)-1-Phenylethanol
by: Joanna Chałupka, et al.
Published: (2023-01-01)

Extraction of lipase from Burkholderia cepacia by PEG/Phosphate ATPS and its biochemical characterization
by: Giovana da Silva Padilha, et al.
Published: (2012-02-01)

Enantioselective Chromatographic Separation and Lipase Catalyzed Asymmetric Resolution of Biologically Important Chiral Amines
by: Mohammed Farrag El-Behairy, et al.
Published: (2021-09-01)

Infected aortic endograft with an unusual microbe, Burkholderia cepacia
by: Evan E. Foulke, MD, et al.
Published: (2023-12-01)

Cervical osteomyelitis caused by Burkholderia cepacia after rhinoplasty
by: Lenny Weinstein, Christin A. Knowlton, Miriam A. Smith.
Published: (2008-02-01)

Burkholderia cepacia endophthalmitis: An unusual presentation
by: Amarendra Deka, et al.
Published: (2018-01-01)

Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
by: Bryan A. Garcia, et al.
Published: (2018-02-01)

The great mimicker “Burkholderia cepacia”: A case of intra-abdominal abscesses
by: Divya Prabhu, et al.
Published: (2023-04-01)

Burkholderia cepacia-contaminated dentures possibly cause pneumonia
by: Satoshi Matsumoto, et al.
Published: (2023-06-01)

Identification of Burkholderia cepacia strains that express a Burkholderia pseudomallei-like capsular polysaccharide
by: Mary N. Burtnick, et al.
Published: (2024-03-01)

Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?
by: Alex eHorsley, et al.
Published: (2011-12-01)

A case of native valve endocarditis caused by <it>Burkholderia cepacia </it>without predisposing factors
by: Han Seong, et al.
Published: (2011-05-01)

The biofilm produced by Burkholderia cepacia complex: molecular aspects and relationship with exopolysaccharides
by: Lucia Corich, et al.
Published: (2010-12-01)

Clinical case of successful resolution of bilateral pneumonia caused by Burkholderia cepacia complex in a patient with cystic fibrosis
by: D F Sergienko, et al.
Published: (2018-12-01)

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?
by: Gonzalo A. Pradenas, et al.
Published: (2016-04-01)

Isolation And Identification Of Burkholderia Cepacia From Respiratory Secretions In Cyctic Fibrosis Patients
by: Celin Telefian, et al.
Published: (2015-09-01)

Isolation And Identification Of Burkholderia Cepacia From Respiratory Secretions In Cyctic Fibrosis Patients
by: Celin Telefian, et al.
Published: (2015-09-01)

Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis
by: Laura A. Porter, et al.
Published: (2011-11-01)

Prevalence of Burkholderia cepacia recovered from clinical specimens in the Zainoel Abidin general hospital, Banda Aceh, Indonesia
by: Suhartono Suhartono, et al.
Published: (2023-02-01)

Community acquired Burkholderia cepacia sepsis in a patient with megaloblastic anemia: a case report and review of literature
by: M. Abraham, et al.
Published: (2022-03-01)

Microbiological assessment of Burkholderia cepacia complex (Bcc) isolates in Alexandria Main University Hospital
by: Nancy Omar, et al.
Published: (2015-03-01)

Chiral drugs - a standard or a challenge for modern pharmacy? Considerations on selected derivatives of 2-arylpropionic acid.
by: Natalia Kocot, et al.
Published: (2022-03-01)

Endophthalmitis caused by Burkholderia cepacia complex (BCC): clinical characteristics, antibiotic susceptibilities, and treatment outcomes
by: Flavius A. Beca, et al.
Published: (2023-11-01)

Systematic review of healthcare-associated Burkholderia cepacia complex outbreaks: presentation, causes and outbreak control
by: Emmanuel Häfliger, et al.
Published: (2020-09-01)

Comparative Genomics Identified PenR E151V Substitution Associated with Carbapenem-Resistance Burkholderia cepacia Complex and a Novel Burkholderia cepacia Complex Specific OXA-1043 Subgroup
by: Liao YC, et al.
Published: (2023-08-01)

Enantioselective Study on the Biodegradation of Verapamil and Cytalopram by Chiral Capillary Electrophoresis
by: Yolanda Martín-Biosca, et al.
Published: (2021-03-01)

Additives Enhancing the Catalytic Properties of Lipase from Burkholderia cepacia Immobilized on Mixed-Function-Grafted Mesoporous Silica Gel
by: Emese Abaházi, et al.
Published: (2014-07-01)

Clinical and Microbiological Profile of Patients with Bloodstream Infections Caused by Burkholderia cepacia Complex
by: Tasneem Siddiqui, et al.
Published: (2022-09-01)

Environmental Burkholderia cepacia Complex Isolates from Human Infections
by: Adam Baldwin, et al.
Published: (2007-03-01)

Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada
by: David P. Speert, et al.
Published: (2002-02-01)

Comparason of extraction methods for PCR detection of Burkholderia cepacia complex (BCC) from cystic fibrosis patients
by: Ergunay Koray, et al.
Published: (2008-06-01)

The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections.
by: Diana Dawn Semler, et al.
Published: (2012-01-01)

Burkholderia cepacia infection in an infant affected by renal osteodystrophy
by: Andrea Sambri, et al.
Published: (2016-03-01)

Molecular Research Comparing the Probabilities of Burkholderia Cepacia Bacterium Diagnosis Procedures
by: L Maki Al-Nasrawy, et al.
Published: (2022-04-01)

Recent Developments in Enantioselective Scandium-Catalyzed Transformations
by: Hélène Pellissier
Published: (2024-01-01)

Burkholderia cepacia outbreak in immunocompetent children in a tertiary hospital in Turkey: A case series
by: Ceren Cetin, et al.
Published: (2022-01-01)

Relationship between antibiotic susceptibility and biofilm production in a clinical strain of Burkholderia cepacia complex
by: Lucia Corich, et al.
Published: (2012-09-01)

Evaluation of MALDI-TOF MS System for the Identification and Differentiation of Burkholderia cepacia Complex Species
by: Fabiana Caroline Zempulski Volpato, et al.
Published: (2022-06-01)

Antibiotics Resistance among Nosocomial Burkholderia cepacia Isolates Detected in Sebha, Libya
by: Shamsi Abdullah Saad Shamsi, et al.
Published: (2023-03-01)